Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 11, 1995, Pages 2055-2062

  Lupu, Cristina ^a   Lupu, Florea ^a   Dennehy, Ulla ^a   Kakkar, Vijay V ^a   Scully, Michael F ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

confocal microscopy; endothelial cells; thrombin; tissue factor pathway inhibitor

Indexed keywords

ANTICOAGULANT AGENT; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CELL GRANULE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOSIS; UMBILICAL VEIN;

EID: 0028842756     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.11.2055     Document Type: Article

References (43)

1. Stern DM, Handley D, Nawroth PP. Endothelium and the regulation of coagulation. In: Simionescu N, Simiunescu M, eds. Endothelial Cell Biology in Health and Disease. New York, NY: Plenum Press; 1988:275-306.
2. Pearson JD. Vessel wall interactions regulating thrombosis. Br Med Bull. 1994;50:776-788.
3. Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539-7546.
4. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-2843.
5. McGee MP, Li L. Functional differences between intrinsic and extrinsic coagulation pathways-kinetics of factor X activation on human monocytes and alveolar macrophages. J Biol Chem. 1991; 266:8079-8085.
6. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
7. Brox JH, Osterud B, Bjorklid E, Fenton JW II. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol. 1984;57:239-246.
8. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest. 1983;71:1893-1896.
9. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986;163:740-745.
10. Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost. 1991;66: 6-15.
11. Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB. Thrombin-mediated release of factor VIII antigen from human vein endothelial cells in culture. Blood. 1982;60:531-534.
12. Rabiet MJ, Plantier JL, Dejana E. Thrombin-induced endothelial cell dysfunction. Br Med Bull. 1994;50:936-945.
13. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin-1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA. 1986;83:3460-3464.
14. Van Obberghen-Schilling E, Pouyssegur J. Signalling pathways of the thrombin receptor. Thromb Haemost. 1993;66:163-168.
15. Lupu F, Moldovan N, Ryan J, Stern DM, Simionescu N. Intrinsic procoagulant surface induced by hypercholesterolemia on rabbit aortic endothelium. Blood Coagul Fibrinolysis. 1993;4:743-752.
16. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71: 335-343.
17. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ. Functional significance of the Kunitz-type inhibitor domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338:518-520.
18. Hansen J-B, Huseby N-E, Sandset PM, Svensson B, Lyngmo V, Nordoy A. Tissue-factor pathway inhibitor and lipoproteins: evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb. 1994;14:223-229.
19. Novotny WF, Girard TJ, Miletich JP, Broze GJ. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989;264:18832-18837.
20. Lindhal AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis. 1992;3: 439-449.
21. Novotny WF, Girard TJ, Miletich JP, Broze GJ. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 1988;72: 2020-2025.
22. Sprecher CA, Kisiel W, Mathewes S, Foster DC. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A. 1994;91: 3353-3357.
23. Abildgaard U. Heparin/low molecular weight heparin and tissue factor pathway inhibitor. Haemostasis. 1993;23(suppl 1):103-106.
24. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release_of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 1988;50: 803-813.
25. Ameri A, Kuppuswamy N, Basu S, Bajaj SP. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood. 1992;79:3219-3226.
26. Kazama Y, Komiyama Y, Kisiel W. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood. 1993;81:676-682.
27. McGee MP, Foster S, Wang X. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes: a potential mechanism for localized control of blood coagulation. J Exp Med. 1994;179:1847-1854.
28. Edgell CJS, McDonald CG, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734-3737.
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52: 2745-2756.
30. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic Protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994;144: 975-985.
31. Garcia JGN, Patterson C, Bahler C, Aschner J, Hart CM, English D. Thrombin receptor activating peptides induce Ca mobilization barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J Cell Physiol. 1993;156:541-549.
32. Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stern DM. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood. 1992;80:966-974.
33. Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul Fibrinolysis. 1991;2:425-433.
34. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol. 1982;95:355-360.
35. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99.
36. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. In: Brakman P, Kluft C, eds. Plasminogen Activation in Fibrinolysis, in Tissue Remodeling and in Development. Ann N Y Acad Sci. 1992:249-258.
37. Richardson M, Tinlin S, De Reske M, Webster S, Senis Y, Giles AR. Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo. Arterioscler Thromb. 1994;14:990-999.
38. Hyslop S, de Nucci G. Heparin, polycations and atherosclerosis. Semin Thromb Hemost. 1993;19:89-98.
39. Sandset PM, Lund H, Norseth J, Abildgaard U, Ose L. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb. 1991;11:138-145.
40. Lupu F, Lupu C, Scully MF, Das S, Kakkar VV. Localisation of tissue factor pathway inhibitor in normal and atherosclerotic vessels. Thromb Haemost. 1995;73:1184. Abstract.
41. Kaneko H, Kakkar VV, Scully MF. Mercury compounds induce a rapid increase in procoagulant activity of monocyte-like U937 cells. Br J Haematol. 1994;87:87-93.
42. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost. 1995;74:134-138.
43. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264:4743-4746.